Results of Second-Look Laparotomy in Advanced Stage Epithelial Ovarian Cancer and Factors Influencing the Results

被引:0
|
作者
Kose, Faruk Mehmet [1 ]
Turan, Taner [1 ]
Boran, Nurettin [1 ]
Karacay, Ozlem [1 ]
Tulunay, Gokhan [1 ]
Koc, Sevgi [1 ]
Aykan, Burcu [1 ]
机构
[1] Etlik Obstet & Gynecol Training & Res Hosp, Oncol Dept, Ankara, Turkey
关键词
ovarian cancer; second-look laparotomy; prognostic factor;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aim of the study was to determine the results of second-look laparotomy (SLL) in patients with stage III C and IV epithelial ovarian cancer and factors influencing the results. Materials and Methods: Medical records of seventy-five patients who underwent SLL between January 1998 and March 2003 were reviewed. The outcome of the SLL procedure and recurrence rates in SLL negative patients were evaluated. The effect of patient age, tumor stage, grade, size, and histological type, presence of ascites, volume of ascites, peritoneal cytology and type of chemotherapy on SLL results were also evaluated. Results: The mean age of the patients was 52 years and mean duration of follow-up was 39 months. In this study, fifty patients received paclitaxel/platinum (six courses) and twenty-five patients received epirubicin/paclitaxel/platinum (six courses) chemotherapy. Of these 75 patients, 47 (62.7%) were SLL negative, 15 (20%) had microscopic residual disease and 13 (17.3%) had gross macroscopic disease. Recurrence occurred in 20 (42.6%) of 47 SLL negative patients. The mean time to recurrence was 14.5 months. The volume of ascites correlated positively with the probability of finding residual tumor at SLL (p<0.05). Patient age, clinical stage, histological type and grade, tumor size, presence of ascites and result of peritoneal cytology were found not to influence the outcome of SLL. Discussion: It is difficult to determine the factors influencing the outcome of SLL because of the insadequacy of the procedure. It is generally considered that SLL doesn't contribute to survival but only gives information about the state of the disease.
引用
收藏
页码:302 / 305
页数:4
相关论文
共 50 条
  • [31] Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial
    Dell' Anna, T.
    Signorelli, M.
    Benedetti-Panici, P.
    Maggioni, A.
    Fossati, R.
    Fruscio, R.
    Milani, R.
    Bocciolone, L.
    Buda, A.
    Mangioni, C.
    Scambia, G.
    Angioli, R.
    Campagnutta, E.
    Grassi, R.
    Landoni, F.
    BRITISH JOURNAL OF CANCER, 2012, 107 (05) : 785 - 792
  • [32] Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: A non-randomized comparison using an explanatory analysis: A Gynecologic Oncology Group study
    Greer, BE
    Bundy, BN
    Ozols, RF
    Fowler, JA
    Clarke-Pearson, D
    Burger, RA
    Mannel, R
    DeGeest, K
    Hartenbach, EM
    Baergen, RN
    Copeland, LJ
    GYNECOLOGIC ONCOLOGY, 2005, 99 (01) : 71 - 79
  • [33] Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: Long-term follow-up
    Goldberg, H
    Stein, ME
    Steiner, M
    Sprecher, E
    Beck, D
    Kuten, A
    TUMORI JOURNAL, 2001, 87 (04): : 248 - 251
  • [34] A risk model for ovarian carcinoma patients using CA 125 - Time to normalization renders second-look laparotomy redundant
    Frasci, G
    Conforti, S
    Zullo, F
    Mastrantonio, P
    Comella, G
    Comella, P
    Persico, G
    Iaffaioli, RV
    CANCER, 1996, 77 (06) : 1122 - 1130
  • [35] What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
    Bese, T
    Demirkiran, F
    Arvas, M
    Oz, AU
    Kosebay, D
    Erkun, E
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (01) : 42 - 45
  • [36] Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma
    Littell, Ramey D.
    Hallonquist, Heidi
    Matulonis, Ursula
    Seiden, Michael V.
    Berkowitz, Ross S.
    Duska, Linda R.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 570 - 574
  • [37] Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
    Fruscio, R.
    Corso, S.
    Ceppi, L.
    Garavaglia, D.
    Garbi, A.
    Floriani, I.
    Franchi, D.
    Cantu, M. G.
    Bonazzi, C. M.
    Milani, R.
    Mangioni, C.
    Colombo, N.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 138 - 144
  • [38] Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study
    Akahira, JI
    Yoshikawa, H
    Shimizu, Y
    Tsunematsu, R
    Hirakawa, T
    Kuramoto, H
    Shiromizu, K
    Kuzuya, K
    Kamura, T
    Kikuchi, Y
    Kodama, S
    Yamamoto, K
    Sato, S
    GYNECOLOGIC ONCOLOGY, 2001, 81 (03) : 398 - 403
  • [39] Robotic approach for ovarian cancer: Perioperative and survival results and comparison with laparoscopy and laparotomy
    Magrina, Javier F.
    Zanagnolo, Vanna
    Noble, Brie N.
    Kho, Rosanne M.
    Magtibay, Paul
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : 100 - 105
  • [40] The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer
    Mahtab Yazdian
    Harald Groeben
    Beyhan Ataseven
    Stephanie Schneider
    Thais Baert
    Mareike Bommert
    Alexander Traut
    Alexandra Elfers-Wassenhoven
    Ulrich Brüß
    Richard Schwameis
    Andreas du Bois
    Uwe Wagner
    Philipp Harter
    Archives of Gynecology and Obstetrics, 2022, 305 : 1311 - 1318